Growing concerns after FDA announces nationwide Adderall shortage

ABC15 2022-10-20

Views 0

There is growing concern among parents after the Food and Drug Administration (FDA) announced a nationwide shortage of Adderall.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
FDA Announces Nationwide Shortage of EpiPens
play
01:18

FDA Announces Nationwide Shortage of EpiPens
Adderall shortage impacting ADHD sufferers nationwide _ USA TODAY
play
01:24

Adderall shortage impacting ADHD sufferers nationwide _ USA TODAY
FDA warns about possible Adderall shortage
play
01:53

FDA warns about possible Adderall shortage
Cheese Sold Nationwide at Whole Foods, Albertsons, More Recalled Due to Listeria Concerns
play
00:58

Cheese Sold Nationwide at Whole Foods, Albertsons, More Recalled Due to Listeria Concerns
Jif Peanut Butter Recalled From Walmart, Sam's Club, and Other Retailers Nationwide Due to Salmonella Concerns
play
00:41

Jif Peanut Butter Recalled From Walmart, Sam's Club, and Other Retailers Nationwide Due to Salmonella Concerns
FDA Recalls Heart Drug Due to Cancer Concerns
play
00:58

FDA Recalls Heart Drug Due to Cancer Concerns
FDA concludes
play
01:46

FDA concludes "no specific concerns" identified to Moderna's COVID-19 vaccine
FDA: Vidalia Onion Recall Due To Listeria Concerns Affects Wegmans, Publix, 5 States - 1breakingnews
play
03:04

FDA: Vidalia Onion Recall Due To Listeria Concerns Affects Wegmans, Publix, 5 States - 1breakingnews
FDA warning against dog bones this holiday season concerns some pet parents
play
01:19

FDA warning against dog bones this holiday season concerns some pet parents
Are Your Drinks Putting Your Health at Risk? FDA Proposes Banning Controversial Beverage Ingredient Amid Health Concerns
play
00:36

Are Your Drinks Putting Your Health at Risk? FDA Proposes Banning Controversial Beverage Ingredient Amid Health Concerns
Govt's Nationwide Facial Recognition System Has Serious Surveillance & Privacy Concerns
play
05:07

Govt's Nationwide Facial Recognition System Has Serious Surveillance & Privacy Concerns
FDA concludes
play
01:51

FDA concludes "no specific concerns" identified in Moderna's COVID-19 vaccine